Webbplats analys parexel.com
CRO & Biopharmaceutical Services | Parexel
Genereras på Mars 07 2026 21:15 PM
Gammal statistik? UPDATERA !
Ställningen är 60/100
SEO Innehåll
Titel
CRO & Biopharmaceutical Services | Parexel
Längd : 42
Perfekt, din titel innehåller mellan 10 och 70 tecken.
Beskrivning
For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.
Längd : 129
Bra, din metabeskrivning innehåller mellan 70 och 160 tecken.
Nyckelord
biopharmaceutical services
Bra, din sida innehåller meta-taggar.
Og Meta Egenskaper
Den här sidan drar inte nytta utav Og. Deras taggar möjliggör sociala sökrobotar att bättre strukturera strukturera din sida. Använd denna og generatorn gratis för att skapa dom.
Rubriker
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 2 | 51 | 8 | 32 | 0 |
- [H1] Who we are,
- [H2] While running a triathlon, Andrea stumbled and realized something was wrong.
- [H2] Parexel is proudly among the world’s largest clinical research organizations
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.
- [H3] She had ALS, a condition affecting more than 200,000 people around the world.
- [H3] Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.
- [H3] Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.
- [H3] Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.
- [H3] Lives can change when you design neuroscience trials with speed and precision.
- [H3] We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.
- [H4]
- [H4] Oncology
- [H4] I&I
- [H4] Cell & Gene Therapy
- [H4] Endocrine & Metabolic
- [H4] Resources
- [H4] Regional Websites
- [H4] Quick Links
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
Bilder
Vi hittade 23 bilder på denna webbsida.
Bra, de flesta eller alla dina bilder innehåller alt-attribut
Text/HTML Ratio
Ratio : 24%
Bra, den här sidans förhållande mellan text till HTML-kod är högre än 15, men lägre än 25 procent.
Flash
Perfekt, inga Flash-innehåll har upptäckts på denna sida.
Iframe
Synd, du har Iframes på webbsidorna vilket innebär att innehållet i en Iframe inte kan indexeras.
SEO Länkar
URL Rewrite
Bra. Dina adressfält ser bra ut!
Understreck i URLen
Perfekt! Inga understreck upptäcktes i din webbadress.
In-page länkar
Vi hittade totalt 162 länkar inklusive 0 länk(ar) till filer
| Anchor | Typ | Juice |
|---|---|---|
| Solutions | Interna | Passing Juice |
| Portfolio management and asset valuation | Interna | Passing Juice |
| Early development and innovation | Interna | Passing Juice |
| Integrated clinical development | Interna | Passing Juice |
| Approval and access | Interna | Passing Juice |
| Value substantiation lifecycle management | Interna | Passing Juice |
| Delivery models | Interna | Passing Juice |
| Operational excellence | Interna | Passing Juice |
| Medical affairs | Interna | Passing Juice |
| Study start-up | Interna | Passing Juice |
| Overview | Interna | Passing Juice |
| Building patient insights into assets, profile and claims | Interna | Passing Juice |
| Portfolio optimization | Interna | Passing Juice |
| Asset valuation and indication prioritization | Interna | Passing Juice |
| Early evidence review | Interna | Passing Juice |
| Integrated development strategy and planning | Interna | Passing Juice |
| Phase I Clinical Trials | Interna | Passing Juice |
| Site Alliance Network and KOL Engagement | Interna | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interna | Passing Juice |
| Regulatory Strategy | Interna | Passing Juice |
| Real World Evidence | Interna | Passing Juice |
| Market Access Consulting, Strategy, and Delivery | Interna | Passing Juice |
| Biomarker and Genomic Medicine Strategy | Interna | Passing Juice |
| Integrated evidence generation planning | Interna | Passing Juice |
| Medical Communications | Interna | Passing Juice |
| Phase IIB-IV Clinical Trials | Interna | Passing Juice |
| Real World Evidence | Interna | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interna | Passing Juice |
| Protocol-Driven, Customized Site Solution Strategy | Interna | Passing Juice |
| Patient Inclusion | Interna | Passing Juice |
| Regulatory Strategy, Submissions, Compliance, and Outsourcing | Interna | Passing Juice |
| Market Access Strategy and Delivery | Interna | Passing Juice |
| Clinical Development Technology Optimization | Interna | Passing Juice |
| Clinical Trial Supply & Logistics | Interna | Passing Juice |
| Integrated evidence generation planning | Interna | Passing Juice |
| Medical Communications | Interna | Passing Juice |
| Drug Safety and Pharmacovigilance | Interna | Passing Juice |
| Global Regulatory Submissions and Outsourcing | Interna | Passing Juice |
| Real World Evidence | Interna | Passing Juice |
| Compliance and Risk Management | Interna | Passing Juice |
| Market Access Strategy and Delivery | Interna | Passing Juice |
| Integrated evidence generation planning | Interna | Passing Juice |
| Medical Communications | Interna | Passing Juice |
| Drug Safety and Pharmacovigilance | Interna | Passing Juice |
| Health economics modelling and simulation | Interna | Passing Juice |
| Real-World Evidence, Market Access Strategy and Planning | Interna | Passing Juice |
| Regulatory Compliance | Interna | Passing Juice |
| Lifecycle Optimization | Interna | Passing Juice |
| Integrated evidence generation planning | Interna | Passing Juice |
| Medical Communications | Interna | Passing Juice |
| Gain an advantage through FSP | Interna | Passing Juice |
| Leveraging AI in clinical development | Interna | Passing Juice |
| Medical affairs for clinical trials | Interna | Passing Juice |
| Biotech | Interna | Passing Juice |
| Listen Now | Interna | Passing Juice |
| Therapeutic Expertise | Interna | Passing Juice |
| Neuroscience | Interna | Passing Juice |
| General medicine | Interna | Passing Juice |
| Infectious disease and vaccines | Interna | Passing Juice |
| Immunology | Interna | Passing Juice |
| Oncology | Interna | Passing Juice |
| Hematology | Interna | Passing Juice |
| Cell and gene therapies | Interna | Passing Juice |
| Pediatrics | Interna | Passing Juice |
| Rare diseases | Interna | Passing Juice |
| Overview | Interna | Passing Juice |
| Cell and gene therapy | Interna | Passing Juice |
| Gastroenterology CRO | Interna | Passing Juice |
| Respiratory CRO | Interna | Passing Juice |
| Endocrine & Metabolic CRO | Interna | Passing Juice |
| Cardiovascular CRO | Interna | Passing Juice |
| Women's health CRO | Interna | Passing Juice |
| Critical Care | Interna | Passing Juice |
| Hepatitis B | Interna | Passing Juice |
| Novel treatments in infectious disease | Interna | Passing Juice |
| Ophthalmology CRO | Interna | Passing Juice |
| Dermatology CRO | Interna | Passing Juice |
| Allergy CRO | Interna | Passing Juice |
| Bladder cancer CRO | Interna | Passing Juice |
| Breast cancer CRO | Interna | Passing Juice |
| Gynecologic cancer CRO | Interna | Passing Juice |
| Head and neck cancer CRO | Interna | Passing Juice |
| Lung cancer CRO | Interna | Passing Juice |
| Phase I and rare tumors | Interna | Passing Juice |
| Prostate cancer CRO | Interna | Passing Juice |
| Neurology | Interna | Passing Juice |
| Psychiatry | Interna | Passing Juice |
| Pediatrics | Interna | Passing Juice |
| Rare Diseases | Interna | Passing Juice |
| Lymphoma CRO | Interna | Passing Juice |
| Acute myelogenous leukemia (AML) CRO | Interna | Passing Juice |
| Myelodysplastic syndrome (MDS) CRO | Interna | Passing Juice |
| Multiple Myeloma CRO | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| Insights | Interna | Passing Juice |
| New frontiers in neuroscience | Interna | Passing Juice |
| Precision oncology | Interna | Passing Juice |
| Rare disease drug development | Interna | Passing Juice |
| Cell and gene therapy development | Interna | Passing Juice |
| Patient-guided drug development | Interna | Passing Juice |
| Clinical Trialblazers Podcast | Interna | Passing Juice |
| The Regulatory Navigator | Interna | Passing Juice |
| On The Pulse | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| Participate | Interna | Passing Juice |
| Healthy volunteers | Interna | Passing Juice |
| Patient volunteers | Interna | Passing Juice |
| Patient advocacy groups | Interna | Passing Juice |
| Baltimore | Externa | Passing Juice |
| Los Angeles | Externa | Passing Juice |
| London | Externa | Passing Juice |
| Berlin | Externa | Passing Juice |
| Overview | Interna | Passing Juice |
| Advisory Council | Interna | Passing Juice |
| Patient stories | Interna | Passing Juice |
| Andrea & David's Story | Interna | Passing Juice |
| Stacy's Story | Interna | Passing Juice |
| Anisha's Story | Interna | Passing Juice |
| Rob's Story | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| Sites | Interna | Passing Juice |
| Learn more | Interna | Passing Juice |
| About | Interna | Passing Juice |
| Leadership team | Interna | Passing Juice |
| Global reach | Interna | Passing Juice |
| Our inclusion strategy | Interna | Passing Juice |
| Our ESG strategy | Interna | Passing Juice |
| Compliance, tax & privacy | Interna | Passing Juice |
| Meet us at an event | Interna | Passing Juice |
| Overview | Interna | Passing Juice |
| Board of Directors | Interna | Passing Juice |
| Our ESG strategy | Interna | Passing Juice |
| Compliance & Ethics | Interna | Passing Juice |
| Tax Strategy | Interna | Passing Juice |
| Privacy Policy | Interna | Passing Juice |
| Cookies and other web tracking | Interna | Passing Juice |
| Supplier Data Privacy Requirements | Interna | Passing Juice |
| Terms of Use | Interna | Passing Juice |
| French Gender Pay Data | Interna | Passing Juice |
| UK Gender Pay Data | Interna | Passing Juice |
| UK Modern Slavery Act Statement | Interna | Passing Juice |
| Ireland Gender Pay Data | Interna | Passing Juice |
| Supplier Inclusion Policy | Interna | Passing Juice |
| Newsroom | Interna | Passing Juice |
| Academy | Externa | Passing Juice |
| Careers | Interna | Passing Juice |
| 中国 (China) | Interna | Passing Juice |
| 日本 (Japan) | Interna | Passing Juice |
| Contact Us | Interna | Passing Juice |
| Oncology | Interna | Passing Juice |
| Immunology | Interna | Passing Juice |
| Cell & Gene Therapy | Interna | Passing Juice |
| Endocrine & Metabolic | Interna | Passing Juice |
| See neuroscience capabilities | Interna | Passing Juice |
| Explore neuroscience careers | Interna | Passing Juice |
| biopharmaceutical leaders and sites | Interna | Passing Juice |
| Contact us | Interna | Passing Juice |
| My Communication Preferences | Interna | Passing Juice |
| Invoicing | Interna | Passing Juice |
| PO Terms and Conditions | Interna | Passing Juice |
SEO Nyckelord
Nyckelord Moln
clinical more overview strategy access development trials medical patient cro
Nyckelord Konsistens
| Nyckelord | Innehåll | Titel | Nyckelord | Beskrivning | Rubriker |
|---|---|---|---|---|---|
| clinical | 55 |  |
|
|
 |
| cro | 50 | |
|
|
|
| overview | 44 | |
|
|
|
| development | 36 | |
|
|
|
| strategy | 30 | |
|
|
|
Användbarhet
Url
Domän : parexel.com
Längd : 11
Favikon
Bra, din webbplats har en favicon.
Utskriftbart
Vi kunde inte hitta CSS för utskrifter.
Språk
Bra. Ditt angivna språk är en.
Dublin Core
Denna sida drar inte nytta utav Dublin Core.
Dokument
Doctype
HTML 5
Encoding
Perfekt. Din deklarerade teckenuppsättning är UTF-8.
W3C Validity
Errors : 0
Varningar : 0
E-post Sekretess
Bra! Ingen e-postadress har hittats i klartext.
Föråldrad HTML
Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.
Hastighets Tips
|
Utmärkt, din webbplats använder inga nästlade tabeller. |
|
Synd, din webbplats använder sig utav inline stilar. |
|
Synd, din webbplats har för många CSS-filer (fler än 4 stycken). |
|
Synd, din webbplats har för många JS filer (fler än 6 stycken). |
|
Perfekt, din webbplats utnyttjar gzip. |
Mobil
Mobiloptimering
|
Apple Ikon |
|
Meta Viewport Tagg |
|
Flash innehåll |
Optimering
XML Sitemap
Bra, din webbplats har en XML sitemap.
| https://www.parexel.com/sitemap.xml |
Robots.txt
https://parexel.com/robots.txt
Bra, din webbplats har en robots.txt fil.
Analytics
Saknas
Vi hittade inte någon analysverktyg på din webbplats.
Webbanalys program kan mäta besökare på din webbplats. Du bör ha minst ett analysverktyg installerat, men det kan också vara en bra ide att installera två för att dubbelkolla uppgifterna.
PageSpeed Insights
Enhet
Kategorier
Free SEO Testing Tool
Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats